Logan Ridge Finance Corporation Announces Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

Reports a Strong Fourth Quarter with Net Investment Income of $0.23 Per Share, Which Marks its Second Consecutive Quarter of Positive Net Investment Income and More Than Triples the Net Investment Income Reported in the Prior Quarter Restores Quarterly Distribution; Announces $0.18 Per Share Distribution for the First Quarter of 2023 Board of Directors Authorizes a $5.0 Million Share Repurchase Program NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — Logan Ridge Finance Corporation (“Logan Ridge”, “LRFC” or the “Company”) (Nasdaq: LRFC) announced today its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Highlights Reported positive Net Investment Income (“NII”) of $0.6 million or $0.23 per share, which marks the Company’s second consecutive quarter of positive NII. Net asset value...

Oil-Dri Announces Record Sales for the Second Quarter and First Six-Months of Fiscal Year 2023

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six-months of fiscal year 2023. Second Quarter Year to Date (in thousands, except per share amounts) Ended January 31, Ended January 31, 2023 2022 Change 2023 2022 Change Consolidated Results Net Sales $101,669 $87,210 17 % $200,208 $169,670 18 % Net Income Attributable to Oil-Dri $3,856 $2,002 93 % $9,097 $2,587 252 % Net Income Attributable to Oil-Dri Excluding Landfill Modification† $5,833 $2,002 191 % $11,074 $2,587 328 % Earnings per Common Diluted Share $0.56 $0.28 100 % $1.34 $0.37 262 % Earnings per Common Diluted Share Excluding Landfill Modification† $0.85 $0.28 204 % $1.63 $0.37 341 % Business...

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

– On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with First Participant Dosed and Others in Screening – – Initial Clinical Data from Gene Therapy Trial for Hunter Syndrome Anticipated in Second Half of 2023; Trial Recruiting in the U.S. and Canada – – Anticipated Cash Runway Into Fourth Quarter 2024 Enables Execution Against Key Milestones – BEDFORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the fourth quarter and full year ended December 31, 2022, and highlighted recent accomplishments. “We entered 2023 with strong momentum across our gene editing and gene therapy clinical trials for PKU and Hunter syndrome, and we anticipate initial data read-outs from...

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

— Preliminary data from GRANITE Phase 2/3 study (individualized vaccine for first-line microsatellite-stable colorectal cancer [MSS-CRC]) remain expected in 4Q 2023 — — Phase 1/2 efficacy signals from “off-the-shelf” vaccine program (SLATE) consistent with those from GRANITE; randomized study of SLATE in patients with newly-diagnosed metastatic cancer to initiate in 2H 2023 — — Clinical evidence building for differentiation of self-amplifying mRNA (samRNA) as a potential next-gen mRNA platform in infectious disease — — Cash, cash equivalents, marketable securities, and restricted cash of $185.2 million as of December 31, 2022 — — Gritstone to host conference call today at 4:30pm ET — EMERYVILLE, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS),...

Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

– Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2 2023 – – Medical Meeting Presentations Highlight Significant Potential of CLS-AX Based on Positive OASIS Phase 1/2a Safety Data, Durability, and Biologic Effect Over 6 Months – – Continued Growth in Retinal Specialists Trained in Suprachoroidal Space (SCS®) Injection Procedure Using FDA-Approved XIPERE® – – Management to Host Webcast and Conference Call Today at 4:30 P.M. ET – ALPHARETTA, Ga., March 09, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a corporate...

AvePoint Announces Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

Full year SaaS revenue of $117.2 million, representing 37% year-over-year growth, 46% adjusted for constant currencyFull year total revenue of $232.3 million, representing 21% year-over-year growth, 29% adjusted for constant currencyTotal ARR of $201.7 million, representing 27% year-over-year growth, 32% adjusted for FX impact JERSEY CITY, N.J., March 09, 2023 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced platform to optimize SaaS operations and secure collaboration, today announced financial results for the fourth quarter and full year ended December 31, 2022. “Our fourth quarter results were a strong close to 2022, highlighted by 32% ARR growth and 26% revenue growth, both adjusted for the impact of FX,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder of AvePoint. “Despite an uncertain macro environment, our strong...

New York Mortgage Trust Declares First Quarter 2023 Common Stock Dividend of $0.40 Per Share, and Preferred Stock Dividends

Written by Customer Service on March 9, 2023. Posted in Dividend Reports And Estimates.

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.40 per share on shares of its common stock for the quarter ending March 31, 2023. The dividend will be payable on April 26, 2023 to common stockholders of record as of the close of business on March 20, 2023. In addition, the Board declared cash dividends on the Company’s 8.000% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”), 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series E Preferred Stock”), 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”) and 7.000% Series G Cumulative Redeemable...

Frequency Electronics, Inc. Announces Third Quarter Fiscal Year 2023 Financial Results

Written by Customer Service on March 9, 2023. Posted in Dividend Reports And Estimates.

MITCHEL FIELD, N.Y., March 09, 2023 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the three- and nine-month periods of fiscal 2023, ended January 31, 2023, of approximately $10.6 million and $27.8 million, respectively, compared to revenues of $12.2 million and $38.1 million, respectively, for the same periods of fiscal 2022, ended January 31, 2022. Operating income for the third quarter of fiscal 2023 was $325,000 compared to an operating loss of $721,000 for the same period of fiscal 2022. Operating loss for the nine months ended January 31, 2023 was $5.1 million compared to an operating loss of $2.1 million for the nine months ended January 31, 2022. Net loss from operations for the three and nine months ended January 31, 2023 was $316,000 or ($0.03) per diluted...

REE Automotive, Ltd. Announces Date for Fourth Quarter 2022 Earnings Release and Conference Call

Written by Customer Service on March 9, 2023. Posted in Public Companies.

TEL-AVIV, Israel, March 09, 2023 (GLOBE NEWSWIRE) — REE Automotive, Ltd. (NASDAQ: REE) (“REE” or the “Company”), an automotive technology company and provider of electric vehicle platforms and EVs, announced today that the Company will release its fourth quarter 2022 financial results before the NASDAQ market opens on Thursday, March 16, 2023. A webcast and conference call will be held on the same date at 8:30 a.m. Eastern time to review the Company’s results, discuss recent events and conduct a question-and-answer session. The live webcast of the conference call can be accessed on the Investors section of the Company’s website at investors.ree.auto. Click here for webcast URL The conference call will be accessible domestically or internationally, by pre-registering in the link provided at investors.ree.auto. Upon registering,...

Nano Dimension Answers over 21 Questions of A Very Confused Shareholder, (a/k/a “Murchinson”) and Possibly More Perplexed “Mr. Marc Bistricer”

Written by Customer Service on March 9, 2023. Posted in Public Companies.

Video Clip, Addressing Misinformation, Fake Data and Manipulation of Truth Waltham, Mass., March 09, 2023 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, released today a video addressing misinformation by a confused shareholder. Click here to watch the video: https://youtu.be/3XMsQ-LNPc0 In this video, Nano Dimension’s Chairman and Chief Executive Officer Yoav Stern will provide clear and concise explanations, clear up any doubts and eradicate misconceptions. We believe that this initiative will promote transparency and reinforce our commitment to keeping our shareholders well-informed, rather than repetitively being exposed...

Day: March 9, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice